Jason Butcher

Circulating tumor cell count is a reliable biomarker for choosing between chemotherapy or endocrine therapy for patients with HER2-negative metastatic breast cancer, according to a recent study published in JAMA Oncology (2020 Nov 5. doi:10.1001/jamaoncol.2020.5660).  “The choice between chemotherapy and endocrine therapy as first-line treatment for [HER2-negative] metastatic breast cancer is usually Read more…

Small Cell Lung Cancer Diagnosis Kristie L. Kahl: To start, can you discuss what the difference is between a small cell and a non-small cell lung cancer diagnosis? Wade T. Iams, MD: Those are the 2 major types of lung cancer, and the difference is the cell type within the lung from Read more…

WASHINGTON — The FDA approved the combination of nivolumab (Opdivo) plus cabozantinib (Cabometyx) on Friday for treating advanced renal cell carcinoma (RCC) in the first-line setting. Support for approval came from CheckMate-9ER, a phase III trial that randomized 651 previously untreated patients with advanced RCC to either sunitinib (Sutent) alone or the combination Read more…

The National Comprehensive Cancer Network (NCCN) today released guidance for COVID-19 vaccinations in patients with cancer. The NCCN created a committee of hematology and oncology experts who specialized in infectious disease, vaccine development and delivers, medical ethics, and health information technology to come up with the recommendations. Read More…

As an emergency physician, Dr. Eugenia South was in the first group of people to receive a covid vaccine. She received her second dose last week  — even before President-elect Joe Biden. Yet South said she’s in no rush to throw away her face mask. Read More…

In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of Read more…

The body’s immune system is the first line of defense against infections like bacteria, viruses or cancers. Some cancers, however, have developed the art of molecular deception to avoid destruction by the body’s immune system. However, a University of Missouri researcher might have found a new way to help the Read more…

Drinking several cups of coffee every day may be linked to a lower risk of developing prostate cancer, suggests a pooled data analysis of the available evidence, published in the online journal BMJ Open. Read More…

Scientists at Dana-Farber Cancer Institute and the Centers for Disease Control and Prevention have uncovered new evidence of the potential health risks of chemicals in tobacco and marijuana smoke. Read More…

CLEVELAND (WJW) – It is one of the most common types of cancer. And close to 300,000 people will be diagnosed with breast cancer in the United States this year alone. But what if breast cancer could be wiped out altogether? Read More…